A Phase 3 interventional study of choleclaciferol in Influenza, sponsored by University of Tromso. Completed at 1 site in Norway. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2011-07-20.
Sponsored by University of Tromso · Phase 3, Interventional, and Prevention
Subjects included in ongoing vitamin d intervention trials were asked by questionnaire if they were ill with influenza during the winter season 2009/2010 to see if vitamin d supplementation prevented flu like disease.
2,214 studies on the registry are indexed under Influenza, Human; 163 are open to participants now.
This study's enrollment of 569 is above the median of 238 across 1,853 interventional studies indexed under Influenza, Human.
Browse Influenza, Human studies →University of Tromso is the lead sponsor of 61 studies on the registry; 7 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
cholecalciferol in doses 800-6000 IU per day
Drug: choleclaciferol
placebo identical looking as cholecalciferol capsules
Drug: choleclaciferol
800-6000 IU cholecalciferol per day
influenza during the winter season 2009/2010
Time frame: up to 30 weeks
This study is completed, as verified in Jul 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Tromso